Sartorius
Price
Price
CHART BY
Historical dividends and forecast
Sartorius has so far distributed $0.791 in 2024. The next dividend will be paid on 04.04.2025
CHART BY
Frequently asked questions
What is Sartorius's market capitalization?
What is Sartorius's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Sartorius?
What are the analyst ratings and target price for Sartorius's stock?
What is Sartorius's revenue over the trailing twelve months?
What is the EBITDA for Sartorius?
What is the free cash flow of Sartorius?
How many employees does Sartorius have, and what sector and industry does it belong to?
What is the free float of Sartorius's shares?
Financials
- Market Cap
- $12.70B
- EPS (TTM)
- $1.263
- Free Float
- 1.49M
- P/E ratio (TTM)
- 145.65
- Revenue (TTM)
- $3.47B
- EBITDA (TTM)
- $909.41M
- Free Cashflow (TTM)
- $292.67M
Pricing
- 1D span
- $177.72$185.11
- 52W span
- $173.52$315.94
Analyst Ratings
The price target is $252.76 and the stock is covered by 5 analysts.
Buy
3
Hold
2
Sell
0
Information
Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through following divisions: Bioprocess Solutions (BPS), and Lab Products and Service (LPS). The Bioprocess Solutions division focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The Lab Products and services division serves the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.
- Employees
- 14,614
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- DE0007165607
- Primary Ticker
- SRT